COMMUNIQUÉS West-GlobeNewswire

Mental Health Commission of Canada e-mental health report provides roadmap for reducing wait times and improving care
09/09/2019
From Mental Health Commission of Canada , Government of Newfoundland and Labrador , and Memorial University ST. JOHN’S, Newfoundland and Labrador, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Today, the Mental Health Commission [...]
Un rapport de la Commission de la santé mentale du Canada sur la cybersanté mentale trace la voie pour réduire les temps d’attente et améliorer les soins de santé
09/09/2019
De la Commission de la santé mentale du Canada , du gouvernement de Terre-Neuve-et-Labrador , et de l’Université Memorial ST. JOHN'S, Terre-Neuve-et-Labrador, 09 sept. 2019 (GLOBE NEWSWIRE) -- Aujourd’hui, la Commission [...]
Crossject : Résultats semestriels et point sur l'activité
09/09/2019
Communiqué de Presse Résultats semestriels 2019 et point d’activité Avancées significatives sur le semestre Signature d’un contrat de commercialisation et poursuite des négociations commerciales Confirmation de l’ [...]
Neovacs : 2019 Financial Calendar
09/09/2019
PRESS RELEASE PRESS RELEASE PRESS RELEASE 2019 Financial Calendar Paris, September 9, 2019, 5:45 pm CEST – NEOVACS (Euronext Growth Paris: ALNEV) leader in active immunotherapy for the treatment of auto-immune and [...]
Néovacs : Agenda financier 2019
09/09/2019
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Agenda financier 2019 Paris et Boston, le 9 septembre 2019 – 17h45 CEST - Néovacs (Euronext Growth Paris : ALNEV), leader de l'immunothérapie active [...]
Spineway : Notice of the Ordinary and Extraordinary General Shareholders’ Meeting to be held 19 september 2019
09/09/2019
Notice of the Ordinary and Extraordinary General Shareholders’ Meeting to be held 19 september 2019 Arrangements for availability of preparatory documents Spineway’s General Shareholders’ Meeting called for 9 a.m. on 16 [...]
SPINEWAY : Convocation à l'Assemblée Générale Mixte du 19 septembre 2019
09/09/2019
Convocation à l'Assemblée Générale Mixte du 19 septembre 2019 Modalités de mise à disposition des documents préparatoires L'Assemblée Générale des actionnaires de Spineway, convoquée le 16 août 2019 à 9 heures au siège [...]
Oxurion NV Reports Additional Positive Topline Data from Phase 1 with THR-149, a Novel, Potent Plasma Kallikrein Inhibitor for DME
09/09/2019
Immediate onset of action - starting from Day 1 with increasing average improvement in Best Corrected Visual Acuity (BCVA) of up to 7.5 letters at Day 14 following a single injection of THR-149. Prolonged durability of [...]
GRAChIE Earns Community Partnership Award For Work During Hurricanes Irma and Florence
09/09/2019
Georgia HIE recognized for establishing rapid connections to facilitate access to vital health data SANDERSVILLE, Ga., Sept. 09, 2019 (GLOBE NEWSWIRE) -- The Georgia Regional Academic Community Health Information [...]
Improving Vitamin D level, physical fitness, and body weight may help to reduce health risks in African-American adults
09/09/2019
DALLAS, Sept. 09, 2019 (GLOBE NEWSWIRE) -- An estimated 40% of American adults may be vitamin D deficient. For African-Americans, that number may be nearly double at 76% according to a new study by The Cooper Institute [...]
Holding(s) in Company TR-1: Standard form for notification of major holdings
09/09/2019
LONDON, Sept. 09, 2019 (GLOBE NEWSWIRE) -- TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i [...]
Transactions under Novozymes’ stock buyback program
09/09/2019
Please read the full announcement in the attached PDF Attachment 2019_34_Stock_Buybackprogram_EN
Genmab and Tempus Enter into Strategic Collaboration Agreement
09/09/2019
Media Release Copenhagen, Denmark, September 9, 2019 Genmab and Tempus sign agreement to research and develop novel targets Genmab A/S (Nasdaq: GMAB) announced today that it has entered into a strategic collaboration [...]
Generex Biotechnology Signs Letter of Intent to Acquire 51% in ALTuCELL, Inc. and their Cellular Therapy Product Altsulin® with Patented Microencapsulation Technology for the Treatment of Type I Diabetes Mellitis
09/09/2019
Patented cell encapsulation technology enables cell implantation for therapeutic and regenerative medicine application without immune system rejection Microcapsules formulated with ultra-purified alginates and poly-L- [...]
Medtronic Announces Reimbursement in Germany for MiniMed™ 670G Insulin Pump System for Individuals with Type 1 Diabetes
09/09/2019
DUBLIN, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it has secured reimbursement for the MiniMed™ 670G insulin pump [...]
Endonovo Partners with Veterans Healthcare Supply Solutions, Appoints Samir Awad, M.D., to Scientific Advisory Board
09/09/2019
LOS ANGELES, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, today announces [...]
Therapeutic Solutions International Reports NanoStilbene™ Protects the Immune System from Cancer Chemotherapy
09/09/2019
Newly Discovered Properties of NanoStilbene Potentially Allows Company to Address $3.9 Billion Chemotherapy Induced Neutropenia Market OCEANSIDE, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Therapeutics Solutions [...]
UPDATE - Auxly Announces Receipt of Key Cannabis Oil Sales Licences for Dosecann and Kolab Project
09/09/2019
VANCOUVER, British Columbia, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced that its wholly-owned subsidiaries, Dosecann Inc. (“ Dosecann ”) and [...]
NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL™-Enabled Therapy on September 16th
09/09/2019
PITTSBURGH, Sept. 09, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing next-generation antisense therapies to address genetic diseases, [...]

Pages